P1061s (10132): Evaluation of Immunologic Memory Following Pneumococcal, Hepatitis B, and Measles Vaccination in HIV-Infected Children Treated with Highly Active Antiretroviral Therapy (HAART)

Study Status Study Restriction

Concluded

Not Applicable

What is P1061s?

P1061s was a follow-up substudy of P1024 study to evaluate the persistence of immunologic memory to pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPV), measles vaccine (MMR), and hepatitis B virus (HBV) vaccine in HIV-infected subjects on HAART who participated in, and completed, P1024.  The study was designed to determine whether HIV-infected children have evidence of pneumococcal type-specific, hepatitis B-specific, and measles-specific immunologic memory 3-4 years after receiving the vaccines while on HAART.

Study Documents:

Sites where the study was implemented:

CRS ID Site Name City Country

5011

Boston Medical Center Pediatric HIV Program

Boston

United States of America

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

Department of Health and Human ServicesNational Institutes of Health

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.